Parametric Risk Advisors’s AbbVie ABBV Stock Holding History

Parametric Risk Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-9,694	Closed	-$574K	–	144
2015 Q4	$574K	Sell	9,694 -114	-1%	-$6.57K	0.04%	111
2015 Q3	$534K	Hold	9,808	–	–	0.03%	113
2015 Q2	$659K	Hold	9,808	–	–	0.04%	110
2015 Q1	$574K	Buy	+9,808	New	+$593K	0.04%	114

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Parametric Risk Advisors's ABBV Position: Q1 2016 in Review

Parametric Risk Advisors sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 9,694 shares — an estimated $574K sold.

Parametric Risk Advisors first reported a position in ABBV in Q1 2015 and held it in 4 quarters. The position peaked at $659K in Q2 2015. 1,638 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Parametric Risk Advisors reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
Parametric Risk Advisors sold 9,694 AbbVie shares in Q1 2016, an estimated $574K.
Parametric Risk Advisors first reported a position in AbbVie in Q1 2015 and held it in 4 quarters.
Parametric Risk Advisors's AbbVie position peaked at $659K in Q2 2015.
1,638 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Parametric Risk Advisors's 13F filing for Q1 2016, filed 13 May 2016.